<DOC>
	<DOCNO>NCT00162955</DOCNO>
	<brief_summary>The purpose study assess protective effect Valsartan chronic cardiotoxicity induce CHOP .</brief_summary>
	<brief_title>Prevention CHOP-induced Chronic Cardiotoxicity</brief_title>
	<detailed_description>Doxorubicin one important key drug treatment malignancy . However , use limited dose-dependent cumulative cardiotoxicity . This multi-centers trial design investigate preventive effect Valsartan , angiotensin II type 1 receptor blocker ( ARB ) chronic cardiotoxicity due doxorubicin base chemotherapy . Patients untreated non-Hodgkin 's lymphoma schedule receive least 6 course standard CHOP ( -R ) randomize minimization method treatment group Valsartan ( 80mg daily oral entire 6 course CHOP ) control group . Cardiac function evaluate detail 3 6 course CHOP ( -R ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Angiotensin II Type 1 Receptor Blockers</mesh_term>
	<criteria>Clinical diagnosis nonHodgkin 's lymphoma ( NHL ) Untreated lymphoma Performance status 0 1 , Total serum bilirubin &lt; 2.0 mg/dl Serum creatinine level &lt; 2.0 mg/dl Ejection fraction leave ventricle &gt; 50 % Systolic blood pressure rest 90 mmHg Severe complication include chronic acute heart failure , angina , old myocardial infarction , liver cirrhosis , interstitial pneumonia Pregnancy , nurse mother woman childbearing potential Hypertension medication Diabetes mellitus medication Hyperthyroidism , nephrotic syndrome , Cushing 's syndrome Atrial arrythmias Severe psychopathy Cerebrovascular accident within past 3 month Positive serum HBs antigen HCV antibody A history renal failure A contraindication AII antagonists noncompliance Treatment follow drug within past 3 month : AII antagonist , ACE inhibitor , vitamin E , probucol , calcium antagonist , betablockers , steroid pulse therapy .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>untreated adult Non-Hodgkin 's Lymphoma</keyword>
	<keyword>CHOP protocol</keyword>
	<keyword>Angiotensin II Type 1 Receptor Blockers</keyword>
	<keyword>Cardiomyopathy</keyword>
</DOC>